Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia/reperfusion through protein-kinase g-dependent generation of hydrogen sulfide
about
Hydrogen sulfide chemical biology: pathophysiological roles and detectionHeart failure with preserved ejection fraction: mechanisms, clinical features, and therapiesTherapeutic potential of PDE modulation in treating heart diseasePhosphodiesterases and cardiac cGMP: evolving roles and controversiesCytoprotection by the modulation of mitochondrial electron transport chain: the emerging role of mitochondrial STAT3Curcumin alleviates diabetic cardiomyopathy in experimental diabetic ratsThe Effect of Sorafenib, Tadalafil and Macitentan Treatments on Thyroxin-Induced Hemodynamic Changes and Cardiac AbnormalitiesEffects of sildenafil and/or muscle derived stem cells on myocardial infarction.Chronic inhibition of phosphodiesterase 5 with tadalafil attenuates mitochondrial dysfunction in type 2 diabetic hearts: potential role of NO/SIRT1/PGC-1α signaling.Aortic valve: mechanical environment and mechanobiology.mTORC2 phosphorylation of Akt1: a possible mechanism for hydrogen sulfide-induced cardioprotection.PDE5 inhibitor efficacy is estrogen dependent in female heart disease.Induction of microRNA-21 with exogenous hydrogen sulfide attenuates myocardial ischemic and inflammatory injury in miceLong-acting phosphodiesterase-5 inhibitor tadalafil attenuates doxorubicin-induced cardiomyopathy without interfering with chemotherapeutic effect.Chronic treatment with long acting phosphodiesterase-5 inhibitor tadalafil alters proteomic changes associated with cytoskeletal rearrangement and redox regulation in Type 2 diabetic hearts.cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.Targeting cyclic nucleotide phosphodiesterase in the heart: therapeutic implications.Cyclic guanosine monophosphate signaling and phosphodiesterase-5 inhibitors in cardioprotection.Anti-inflammatory and cardioprotective effects of tadalafil in diabetic miceProtein kinase G1 α overexpression increases stem cell survival and cardiac function after myocardial infarction.Mitigation of the progression of heart failure with sildenafil involves inhibition of RhoA/Rho-kinase pathwayGas what: NO is not the only answer to sexual function.Altered oxido-reductive state in the diabetic heart: loss of cardioprotection due to protein disulfide isomeraseDiscovery of shear- and side-specific mRNAs and miRNAs in human aortic valvular endothelial cells.Emerging new uses of phosphodiesterase-5 inhibitors in cardiovascular diseases.Tadalafil Integrates Nitric Oxide-Hydrogen Sulfide Signaling to Inhibit High Glucose-induced Matrix Protein Synthesis in PodocytesPDE5 inhibitors as therapeutics for heart disease, diabetes and cancerCinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide.Adenoviral short hairpin RNA therapy targeting phosphodiesterase 5a relieves cardiac remodeling and dysfunction following myocardial infarctionShared signaling pathways among gasotransmitters.Analysis of erectile responses to H2S donors in the anesthetized rat.cGMP-Phosphodiesterase Inhibition Prevents Hypoxia-Induced Cell Death Activation in Porcine Retinal ExplantsHydrogen sulfide and PKG in ischemia-reperfusion injury: sources, signaling, accelerators and brakes.SIRTUIN 1 ACTIVATOR SRT1720 PROTECTS AGAINST ORGAN INJURY INDUCED BY INTESTINAL ISCHEMIA-REPERFUSIONThiosulfate Mediates Cytoprotective Effects of Hydrogen Sulfide Against Neuronal Ischemia.Oncostatin M-induced cardiomyocyte dedifferentiation regulates the progression of diabetic cardiomyopathy through B-Raf/Mek/Erk signaling pathway.Beetroot juice reduces infarct size and improves cardiac function following ischemia-reperfusion injury: Possible involvement of endogenous H2SThioredoxin 1 is essential for sodium sulfide-mediated cardioprotection in the setting of heart failureHydrogen sulfide and erectile function: a novel therapeutic target.Role of hydrogen sulfide in the physiology of penile erection
P2860
Q26824672-E69721F7-668C-43A5-B464-49EC9777FC4EQ27000263-288F03BB-951F-4F21-9B67-EAA05F43AED9Q27005761-98B73B9A-C92E-4AE9-B17F-B5E91C953ABCQ27692588-97434A27-EBAF-4B93-8FB3-BE5AED9A60A6Q28396645-B04C9B46-1F0E-4288-BC0E-14BD9A10B810Q28484372-29895B92-AA75-4E25-8B51-174018519B37Q28551385-E5930E81-A7EF-4D94-858A-F7ACC77967B3Q30462352-53F36E9D-95B4-4698-B68E-E7C9BD696926Q33701938-05F066CD-0808-4E68-BF97-3E3B2C3115F8Q33767188-71327F2B-0D3C-45A1-9EE2-6FF15604143CQ33783826-A2F09261-1F02-4D20-8D61-E95D5AA0DEEEQ33872491-E7134989-4321-4A8C-A0B0-61D32A330AA4Q33874591-D29C384D-EFB9-4C5C-9499-AC2ACE906FBAQ34128868-AA338557-2E0A-469C-9136-483BCD3AB517Q34152435-24F57822-29F9-4009-8152-CB0527EC881EQ34244951-59F75FB8-585C-4D7D-A9C2-080AB9480938Q34252901-2061A7F4-2937-4D57-8BB5-1278FAD4C8C8Q34277031-6969FBB6-AA60-468C-9475-D6491C59989EQ34428464-13DCAD8D-6C51-4378-B1AA-91B4C37CECDBQ34639920-DB78A99B-7BB6-4F56-972B-71E9AEDCD139Q35056906-4C0B4A72-8171-4F5C-91EF-CA6738E96C20Q35204833-73DB18AD-8E61-4968-BF34-6061F9DCDE06Q35286858-3CC9D033-789E-4624-912E-DD0D62912503Q35315207-B9383CEB-182C-4450-933D-A0BC5096A705Q35500693-376AD599-7D58-47AC-BCA5-FADF8CF272BFQ35583071-864678E1-E4CC-4E7D-9500-48D80443040BQ35827798-EE36BFF6-A03F-452A-B61E-6009FB004B53Q35850118-A33F3332-ECC3-494A-B21C-8A2E2C395EBCQ35994136-5A216E73-CFB7-4271-8657-1D462759B3E7Q36061562-BEFEFC96-8702-4E7B-BC56-0278BCE8D608Q36114282-8722DCD6-C68A-4D94-B041-297490DC258CQ36197680-59F4D952-3918-4B0C-8AB7-70FE3AE623CCQ36341617-C2B1FC3D-BCB7-4408-9D08-B2581E36505AQ36689329-415190DB-FCB8-49D3-AC23-632D5810EB6DQ36836222-ECBE5613-C010-4D32-BC5D-6F611227E7C3Q36947121-C05128DA-6D2F-4CAA-8CFB-12D7F6779CF9Q37071148-0D726DAC-6191-43E6-93ED-DFA6558BCAF1Q37307617-093560E9-C1AD-43B6-B82E-569BE0B502CFQ37862060-DD4E909B-99A7-477E-8BAA-AE71BBB0B5F6Q37948024-9ADE176C-CEF2-4E6A-A623-9CEB16F76ADE
P2860
Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia/reperfusion through protein-kinase g-dependent generation of hydrogen sulfide
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Phosphodiesterase-5 inhibitor, ...... generation of hydrogen sulfide
@ast
Phosphodiesterase-5 inhibitor, ...... generation of hydrogen sulfide
@en
Phosphodiesterase-5 inhibitor, ...... generation of hydrogen sulfide
@nl
type
label
Phosphodiesterase-5 inhibitor, ...... generation of hydrogen sulfide
@ast
Phosphodiesterase-5 inhibitor, ...... generation of hydrogen sulfide
@en
Phosphodiesterase-5 inhibitor, ...... generation of hydrogen sulfide
@nl
prefLabel
Phosphodiesterase-5 inhibitor, ...... generation of hydrogen sulfide
@ast
Phosphodiesterase-5 inhibitor, ...... generation of hydrogen sulfide
@en
Phosphodiesterase-5 inhibitor, ...... generation of hydrogen sulfide
@nl
P2093
P2860
P1433
P1476
Phosphodiesterase-5 inhibitor, ...... generation of hydrogen sulfide
@en
P2093
Amit Varma
Antonio Abbate
Fadi N Salloum
Nicholas N Hoke
Rakesh C Kukreja
Ramzi A Ockaili
Stefano Toldo
Vinh Q Chau
P2860
P356
10.1161/CIRCULATIONAHA.108.843979
P407
P433
P577
2009-09-01T00:00:00Z